Drugs in Dev.
Endocrinology
Discovery Platform
United Kingdom 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Study Phase : Discovery Platform
Sponsor : Eli Lilly
Deal Size : $15.0 million
Deal Type : Agreement
MiNA Therapeutics Announces Equity Investment from Lilly
Details : Proceeds from the equity investment will be used to advance and expand MiNA’s internal pipeline of saRNA therapeutics, which is initially focused on immuno-oncology and genetic diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 06, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Endocrinology
Highest Development Status : Discovery Platform
Sponsor : Eli Lilly
Deal Size : $15.0 million
Deal Type : Agreement
